Updated interpretation of Chinese Society of Clinical Oncology(CSCO)Guidelines for the Diagnosis and Treatment of Non-small Cell Lung Cancer 2024
The Chinese Society of Clinical Oncology(CSCO)Guidelines for the Diagnosis and Treat-ment of Non-small Cell Lung Cancer 2024 Hereinafter referred to as the CSCO Guidelines for Non Small Cell Lung Cancer(NSCLC)in 2024 was officially released in April 2024.The new version of the CSCO Guidelines for NSCLC in 2024 adhered to the evidence-based medical evidence,focused on the accessibility of drugs,taking into account regional development differences and pharmacoeconomic costs,summarizing expert opinions,and timely updating the diagnosis and treatment of NSCLC on the basis of the 2023 version.This pa-per aimed to sort out and analyze the updated part of the CSCO Guidelines for NSCLC in 2024,focusing on the update points of immunotherapy and targeted therapy and the corresponding evidence-based medical evi-dence.
万方数据
维普
